0001213900-22-008257.txt : 20220217 0001213900-22-008257.hdr.sgml : 20220217 20220217161324 ACCESSION NUMBER: 0001213900-22-008257 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 EFFECTIVENESS DATE: 20220217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001513525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 800667150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-434070 FILM NUMBER: 22648233 BUSINESS ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 BUSINESS PHONE: 434-422-9800 MAIL ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 FORMER COMPANY: FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20170515 FORMER COMPANY: FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20110218 D 1 primary_doc.xml X0708 D LIVE 0001513525 ADIAL PHARMACEUTICALS, INC. 1180 SEMINOLE TRAIL, SUITE 495 CHARLOTTESVILLE VA VIRGINIA 22901 (434) 422-9800 DELAWARE Adial Pharmaceuticals L.L.C. ADial Pharmaceuticals, L.L.C. Adial Pharmaceuticals, L.L.C. Corporation true 2017 William B. Stilley, III 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22902 Executive Officer Director Joseph M. Truluck 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Executive Officer James K. Anderson 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Robertson H. Gilliland 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Bankole A. Johnson 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Executive Officer James W. Newman, Jr. 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Kevin Schuyler, CFA 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Tony Goodman 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Cary Claiborne 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2022-02-11 false true true false 0 Maxim Group LLC 120708 None None THE CHRYSLER BUILDING 405 LEXINGTON AVENUE, 26TH FLOOR NEW YORK NY NEW YORK 10174 CA CALIFORNIA IL ILLINOIS NY NEW YORK false 10000000 10000000 0 The Issuer issued securities in a registered direct offering for gross proceeds of approximately $10,000,000 and warrants in a concurrent private placement having an aggregate exercise price of approximately $10,000,000 false 1 700000 true 0 Commission was paid for the securities issued in the registered direct offering 0 true While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false ADIAL PHARMACEUTICALS, INC. /s/ William B. Stilley, III William B. Stilley, III Chief Executive Officer 2022-02-17